134 related articles for article (PubMed ID: 3040286)
1. Elevation of plasma levels of fluorinated pyrimidines by guanosine 5'-monophosphate.
Iigo M; Yamaizumi Z; Nishimura S; Hoshi A
Cancer Chemother Pharmacol; 1987; 20(1):1-4. PubMed ID: 3040286
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
Iigo M; Miwa M; Ishitsuka H; Nitta K
Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
[TBL] [Abstract][Full Text] [Related]
3. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).
Beumer JH; Parise RA; Newman EM; Doroshow JH; Synold TW; Lenz HJ; Egorin MJ
Cancer Chemother Pharmacol; 2008 Jul; 62(2):363-8. PubMed ID: 17899082
[TBL] [Abstract][Full Text] [Related]
5. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
[TBL] [Abstract][Full Text] [Related]
6. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
Iigo M; Hoshi A
Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
Iigo M; Yamaizumi Z; Nakajima Y; Nishimura S; Hoshi A
Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897
[TBL] [Abstract][Full Text] [Related]
8. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
Iigo M; Hoshi A
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
Iigo M; Kuretani K; Hoshi A
Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
[TBL] [Abstract][Full Text] [Related]
10. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
Mekras JA; Boothman DA; Perez LM; Greer S
Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice.
Beumer JH; Eiseman JL; Parise RA; Joseph E; Holleran JL; Covey JM; Egorin MJ
Clin Cancer Res; 2006 Dec; 12(24):7483-91. PubMed ID: 17138702
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells.
Kaysen J; Spriggs D; Kufe D
Cancer Res; 1986 Sep; 46(9):4534-8. PubMed ID: 2425957
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of potentiation of antitumor activity of 5-fluorouracil by guanine ribonucleotides against adenocarcinoma 755.
Iigo M; Yamaizumi Z; Nishimura S; Hoshi A
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):1059-65. PubMed ID: 3665991
[TBL] [Abstract][Full Text] [Related]
14. A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.
Vainchtein LD; Rosing H; Schellens JH; Beijnen JH
Biomed Chromatogr; 2010 Apr; 24(4):374-86. PubMed ID: 19650151
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological properties of purine and pyrimidine 5'-deoxy-5'-(dihydroxyphosphinyl)-beta-D-ribofuranosyl analogues of AMP, GMP, IMP, and CMP.
Raju N; Smee DF; Robins RK; Vaghefi MM
J Med Chem; 1989 Jun; 32(6):1307-13. PubMed ID: 2542559
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of guanylate cyclase by guanosine 3'-phosphate and 2'-deoxyguanosine 3'-phosphate in silkworm fat body.
Morishima I
J Biochem; 1982 Mar; 91(3):905-9. PubMed ID: 6122683
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
[TBL] [Abstract][Full Text] [Related]
18. Guanine nucleotides modulate TRH-receptor binding in sheep anterior pituitary.
Taylor RL; Burt DR
Mol Cell Endocrinol; 1981 Jan; 21(1):85-91. PubMed ID: 6259003
[TBL] [Abstract][Full Text] [Related]
19. Interactions between guanine derivatives and norepinephrine on neurones of the mammalian cerebral cortex.
Stone TW; Taylor DA
Brain Res; 1978 Oct; 155(1):187-91. PubMed ID: 210892
[No Abstract] [Full Text] [Related]
20. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
Iigo M; Nakajima Y; Kuretani K; Hoshi A
Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
